caladrius
biosciences
present
life
sciences
investor
forum
september
basking
ridge
globe
newswire
caladrius
biosciences
nasdaq
clbs
caladrius
company
biopharmaceutical
company
dedicated
development
cellular
therapies
designed
reverse
manage
disease
announced
today
management
present
company
overview
virtual
life
sciences
investor
forum
held
thursday
september
presentation
details
date
time
thursday
september
edt
presenter
david
mazzo
president
chief
executive
officer
live
interactive
online
event
investors
invited
ask
company
questions
presentation
q
session
webcast
live
accessed
investors
encouraged
expedite
participation
receive
event
updates
please
access
website
least
minutes
advance
scheduled
presentation
time
register
run
online
system
check
please
visit
register
learn
event
caladrius
biosciences
caladrius
biosciences
biopharmaceutical
company
dedicated
development
cellular
therapies
designed
reverse
manage
disease
developing
cell
therapy
products
based
notion
body
contains
finely
tuned
mechanisms
technology
leverages
enables
mechanisms
form
specific
cells
using
formulations
modes
delivery
unique
medical
indication
company
current
product
candidates
include
cell
therapy
product
candidate
repair
lung
damage
found
patients
severe
infection
experienced
respiratory
failure
company
plans
initiate
clinical
trial
coming
weeks
well
three
developmental
treatments
ischemic
diseases
based
cell
therapy
platform
formerly
recipient
sakigake
designation
eligible
early
conditional
approval
japan
treatment
critical
limb
ischemia
cli
based
results
ongoing
clinical
trial
subject
recently
completed
positive
phase
clinical
trial
treatment
coronary
microvascular
dysfunction
cmd
regenerative
medicine
advanced
therapy
rmat
designated
therapy
company
finalized
food
drug
administration
fda
protocol
phase
confirmatory
trial
subjects
refractory
disabling
angina
norda
information
company
please
visit
life
sciences
investor
forum
life
sciences
investor
forum
leading
proprietary
investor
conference
series
provides
interactive
forum
life
sciences
companies
meet
present
directly
investors
solution
investor
engagement
life
sciences
investor
forum
powered
intrado
digital
media
specifically
designed
efficient
investor
access
replicating
look
feel
investor
conferences
life
sciences
investor
forum
combines
conferencing
investor
communications
capabilities
comprehensive
global
investor
audience
network
